JenKem Technology

BEIJING, Sept. 19, 2016 /PRNewswire-iReach/ -- JenKem Technology and the life science business of Merck are pleased to announce a collaboration agreement for the distribution of select JenKem Technology high quality polyethylene glycol (PEG) products for biomedical applications by Merck.
htt...

JenKem Technology’s dedicated and experienced technical support group can help you identify the right high quality PEG derivatives for your pegylation needs. Currently JenKem Technology provides two pegylation service models:

Service model 1. PEGylation services provided as a regular e...

Custom Synthesis of PEG DerivativesJenKem Technology’s services include custom PEG synthesis. JenKem has multiple years of expertise in synthesis of special PEG derivatives.  JenKem Technology’s R&D department will develop and synthesize your desired activated polyethylene glycols to meet the...

JenKem Technology offers large scale GMP manufacture of premium fatty acid side chain products for drug modification, with batch size of 10kg-100kg, with high purity and good lot-to-lot reproducibility. Fatty acid side chains are known to aid in improving patient compliance with increased half-life for Glucagon-like peptide-1 (GLP-1) receptor agonists, which are extensively used in the treatment of type II diabetes and obesity. For example, several drug entities such as tirzepatide, somapacitan, or semaglutide, are modified to incorporate fatty acid side-chains.

Fatty Acid Side Chain – related products and services offered by JenKem Technology:

• Fatty Acid Side-Chain Custom Synthesis• Customized Molecular Coupling Services 
• Characterization of Modified Polypeptide(s) and their Catabolites
• Quality Studies Related to Clinical Studies